CLINICAL_TRIALS
withdrawal
· 2016-10-21
Clinical Trial Update: Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
Summary
This clinical trial evaluating how medications are removed during plasmapheresis in kidney transplant patients has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Kidney Transplantation, Plasmapheresis | Status: WITHDRAWN